Schuchart Aaron

CIK 00017092582 companiesAUSTIN, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001709258

Recent Transactions

27 trades

Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−7,805→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Common Stock
2024-12-12−8,179→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−12,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−45,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−12,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−12,000→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−8,500→ 0 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-04-01+12,000→ 12,000 total
Award
LUMOS PHARMA, INC.
Common Stock
2024-04-01$2.84/sh+1,000→ 6,679 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2024-02-01$3.01/sh−202→ 5,679 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2023-02-01$3.52/sh−104→ 5,381 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2023-02-01+12,000→ 12,000 total
Award
LUMOS PHARMA, INC.
Common Stock
2023-02-01$3.52/sh+1,000→ 5,485 total
Award
LUMOS PHARMA, INC.
Common Stock
2022-02-01$10.02/sh+1,000→ 4,037 total
Tax Payment
LUMOS PHARMA, INC.
Common Stock
2022-02-01$10.02/sh−52→ 3,985 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2022-02-01+12,000→ 12,000 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2021-08-12$7.42/sh+1,700→ 3,037 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2021-08-11$7.35/sh+300→ 1,337 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2021-06-01+7,805→ 7,805 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2019-02-28+60,000→ 60,000 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2018-09-27$9.50/sh−5,900→ 2,500 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2018-09-27$9.55/sh−100→ 8,400 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2018-08-17$3.50/sh+8,500→ 8,500 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2018-08-17−8,500→ 91,500 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2018-02-20+20,000→ 20,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2017-08-22+10,000→ 10,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2017-06-16+100,000→ 100,000 total

Companies

Recent Filings

Address

C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250

AUSTIN, TX, 78746

View on SEC.gov